Clinical Trial

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Name: Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis — clinical trial record (NCT04168099)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis

Trial Details

NCT Number	NCT04168099
Lead Sponsor	Tanta University
Conditions	Spontaneous Bacterial Peritonitis
Enrollment	60 participants
Start Date	2018-12-01
Primary Completion	2028-12-01 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2019-11-19